Philips has released a package of enhancements and new system configurations for its ultrasound portfolio. The upgrades, known collectively as Vision 2005, include new capabilities for the company’s latest radiology and cardiology platforms.
Philips has released a package of enhancements and new system configurations for its ultrasound portfolio. The upgrades, known collectively as Vision 2005, include new capabilities for the company's latest radiology and cardiology platforms.
Highlights include new pediatric cardiology capabilities and enhanced vascular capabilities on the iE33 (cardiology) system, cardiology capabilities and photo-quality 3D fetal imaging on the iU22 (radiology) system, and oncart and offcart upgrades to QLAB Quantification Software on both platforms.
Philips' iE33 (intelligent echo) system and iU22 (intelligent ultrasound) system support traditional 2D as well as 3D and 4D visualization. They use advanced transducer technology (xMATRIX), crystals (PureWave), user-centered ergonomics, and volumetric quantification. Several enhancements build on these core technologies.
On the iE33, 3DQ Advanced software is used to measure the contractility of the heart to help determine which patients are the best candidates for cardiac resynchronization therapy (CRT). Vision 2005 introduces 3D synchronicity indices that can quantify cardiac dyssynchrony and, thereby, standardize 3D evaluation for CRT. The pediatric cardiology package includes a new multiplanar transesophegeal echo transducer optimized for use during pediatric surgery.
On the iU22, Vision 2005 provides faster volume rates and better 4D image quality by incorporating Philips' SonoCT compound imaging. The X3-1 xMATRIX array transducer enables real-time volume-rendered imaging for general viewing as well as cardiac applications. Other enhancements include the ability to measure intima media thickness, an indicator of early atherosclerosis.
The 3D Viewer allows the review and display of 3D data sets and multiplanar reconstructions similar to those used in MR and CT. Analysis tools allow the review of contrast loops and creation of microvascular imaging files that visualize blood flow in extremely small vessels. Cardiac quantification of 3D data sets and strain quantification are also available.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
Improving Adherence to Best Practices for Incidental Abdominal Aortic Aneurysms on CT and MRI
November 5th 2024In recent interviews, Eric Rohren, M.D., and Krishna Nallamshetty, M.D., discuss the potential of abdominal aortic aneurysms (AAAs) to progress into life-threatening consequences and an emerging AI-powered tool that may bolster adherence to best practice recommendations in radiology reporting of incidental AAA findings on CT and MRI.